Clinic
Stat MD Urgent Care, INC
Stat MD Urgent Care, INC was paid $2.44M by Medicaid between Sep 2020 and Sep 2024, across 30 billing codes. Its largest line is U0002, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc — 20% of everything it billed.
33Billing provider infoSTAT MD URGENT CARE, INC
BAKERSFIELD, CA 93311
BAKERSFIELD, CA 93311
33aNPI1902364425assigned 03/04/2019
33bProvider typeUrgent Care Clinic/Center
28Total paid$2.44M
24GClaims57,350
24DCodes billed30
24AFirst – last monthSep 2020 – Sep 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in California
Rank by total paid#47 of 284
Median peer was paid$147K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 394 | $15K | |
| 2021 | 8,261 | $331K | |
| 2022 | 27,206 | $1.05M | |
| 2023 | 15,311 | $627K | |
| 2024incomplete | 6,178 | $415K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 20% | 9,650 | 7,962 | $491K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 9,117 | 7,461 | $423K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 17% | 10,043 | 8,406 | $410K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 16% | 4,356 | 4,334 | $393K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.3% | 5,777 | 4,510 | $203K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.6% | 7,944 | 6,374 | $185K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.1% | 2,726 | 2,448 | $173K |
| 94060 | 3.1% | 1,384 | 1,338 | $76K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 297 | 296 | $29K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,519 | 1,466 | $23K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 594 | 544 | $13K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 462 | 452 | $6K |
18 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 443 | $3K |
| 94664 | <1% | 177 | $3K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 116 | $2K |
| 90655 | <1% | 70 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 29 | $2K |
| 90674 | <1% | 54 | $2K | |
| 81002 | <1% | 697 | $1K | |
| 87807 | <1% | 125 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $671.58 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 29 | $530.43 |
| 93000 | <1% | 12 | $394.68 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 64 | $381.98 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 42 | $257.19 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 36 | $164.47 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,528 | $62.18 |
| 81025 | <1% | 13 | $36.40 | |
| G0008 | Administration of influenza virus vaccine | 0% | 13 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSINGH, RAVINDERJIT (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Singh Family Medical Clinic Incorporated | Bakersfield, CA | $7.96M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.